Back to AB Abrams Capital Management, L.P.
AKBA
Showing 0 of 6 quarters
Position history for ABAbrams Capital Management, L.P.'s holdings in Akebia Therapeutics, Inc.
No. Abrams Capital Management exited its AKBA (Akebia Therapeutics) position in Q4 2020. Its Q3 2020 13F listed 5,656,462 shares worth $14.2M. Abrams Capital Management already held AKBA in its Q3 2019 13F, the earliest on record, and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.